Drug Patent Watch

MARCH 4, 2025

The Unseen Heroes of Generic Drug Development: Pharmacovigilance As a generic drug developer, you're no stranger to the challenges of bringing affordable medications to market. But have you ever stopped to think about the unsung heroes of generic drug development?

Drug Development 52

Drug Development Drugs Government Production 52

PPD

DECEMBER 16, 2024

Our annual look at the state of the drug development industry highlights a dual set of challenges complicating progress. Rising costs have become a persistent challenge for drug developers, driven by a combination of internal and external pressures that have intensified in recent years.

Drug Development 52

Drug Development Clinical Trials Compliance Trials 52

PPD

MARCH 11, 2025

Developing treatments for individuals living with rare diseases is critical, but orphan drug development is laden with unique obstacles that necessitate innovative, multifaceted approaches. Data from these studies can accelerate research timelines and improve trial planning throughout the product life cycle.

Drug Development 52

Drug Development Clinical Trials Disease Trials 52

Drug Patent Watch

JULY 25, 2024

Developing a competitive edge in generic drug development is crucial for companies to gain a significant market share and dominate the market. Here are some key strategies and insights from industry…

Drug Development 105

Drug Development Drugs Marketing 105

Drug Target Review

DECEMBER 20, 2024

Artificial intelligence (AI) has revolutionised many industries, yet its adoption in pharmaceutical drug development has been notably slower. For years, AI and machine learning (ML) were often dismissed as little more than advanced statistics with little practical value in drug development.

Clinical Trials 128

Clinical Trials Trials Pharmaceuticals Drug Development 128

Perficient: Drug Development

MARCH 6, 2024

In December 2022, the Department of Health and Human Services released a bulletin announcing additional compliance requirements for healthcare marketers when it comes to third-party trackers. The guidance lays forth expectations for how healthcare organizations collect data on activities that take place on their website and mobile apps.

Marketing 122

Marketing Regulations Compliance Science 122

Drug Patent Watch

JANUARY 30, 2025

Maximizing Patent Protection: Strategies for Pharmaceutical Marketers As a pharmaceutical marketer, you know how crucial it is to protect your patented drug's market share. This exclusivity is a result of the patent protection granted to the drug's developer. Read the full article here: [link]

Marketing 59

Marketing Drugs Production Pharmaceuticals 59

Perficient: Drug Development

MAY 14, 2024

Many healthcare marketers grapple with accessing timely, reliable data to power meaningful campaigns. Enter Perficient’s Patient 360, leveraging Salesforce Data Cloud, Health Cloud and Marketing Cloud – a solution tailored to meet the demands of modern healthcare marketing.

Marketing 111

Marketing Hospitals Science 111

BioPharma Drive: Drug Pricing

SEPTEMBER 30, 2024

Clinical services organizations can help pharma with global drug development and clinical trial challenges.

Clinical Trials 130

Clinical Trials Marketing Drug Development Trials 130

BioPharma Drive: Drug Pricing

NOVEMBER 4, 2024

As novel therapeutics become more complex — and costly — to bring to market, drug developers are looking to unified clinical development platforms to streamline operations.

Production 204

Production Clinical Development Drug Development Marketing 204

PPD

SEPTEMBER 25, 2023

As the clinical trial landscape evolves, drug developers are faced with novel challenges and changes in study recruitment, trial size and structure, and more. The adoption of new innovations, strategies and technologies offers opportunities to address persistent challenges and develop suitable approaches for the future.

Drug Development 104

Drug Development Clinical Trials Drugs Trials 104

DrugBank

OCTOBER 17, 2024

Data science has emerged as an innovative tool in the biopharmaceutical industry, leveraging the power of machine learning and artificial intelligence to drive innovation and efficiency across the entire drug development lifecycle. This was seen in the case of the BRAF V600E mutation test for melanoma patients receiving vemurafenib.

Drug Development 98

Drug Development Metabolic Stability Clinical Trials Drugs 98

Broad Institute

DECEMBER 18, 2023

Brain disorders are difficult to study and many drug candidates have failed in clinical trials, causing pharmaceutical companies to reduce their investments or even exit the field entirely. So the need and the markets are there. What do you think it will take for industry to re-engage in this space?

Drug Development 130

Drug Development Clinical Trials Drugs Disease 130

Fierce BioTech

OCTOBER 21, 2024

Carl Sailer is Vice President of Full Service Solutions at Syneos Health®, a leading fully integrated biopharmaceutical solutions organization providing clinical development and commercialization s | In this conversation with Fierce Biotech, we explore the ever-evolving biotech landscape.

Marketing 98

Marketing Clinical Development Drug Development Drugs 98

Drug Patent Watch

SEPTEMBER 10, 2024

The generic drug market has experienced significant growth over the past few decades, driven by the passage of the Hatch-Waxman Act in 1984 and subsequent legislation. Today, the market is more competitive than ever, with generic drugs accounting for over 90% of all prescriptions in the United States.

Drug Development 105

Drug Development Drugs Marketing 105

BioPharma Drive: Drug Pricing

JULY 17, 2023

With this highly marketable dosage form, scientists can effectively formulate poorly soluble drugs and supplements, while reducing development time and costs.

Drug Development 130

Drug Development Drugs Marketing 130

Perficient: Drug Development

SEPTEMBER 17, 2024

This year, I’m particularly excited about how far we’ve advanced with Optimizely One in collaboration with Perficient, which is described as an operating system for marketing teams. Many organizations are shifting away from piecing together various products to build their marketing technology systems. Will you be at Opticon 2024?

Marketing 109

Marketing Production Government 109

BioPharma Drive: Drug Pricing

FEBRUARY 10, 2025

Shares in the brain drug developer rose by more than 20% Monday on news of the deal, which will forestall Teva's generic copy of Auvelity from entering the U.S. market until at least 2038.

Drug Development 184

Drug Development Marketing Drugs 184

PPD

SEPTEMBER 6, 2023

Mixing of service models — a strategy that drug developers are leveraging now more than ever — can bring life-changing therapies to market faster. Growth of the FSP market is steadily increasing. In 2018, market utilization of FSO models was at 72%, with usage of FSP models lagging at 28%.

Drug Development 98

Drug Development Clinical Trials Drugs Clinical Research 98

Drug Patent Watch

DECEMBER 12, 2024

This approach not only helps maintain market exclusivity but also ensures a steady revenue stream for pharmaceutical companies. In this comprehensive guide, we’ll explore the intricacies of identifying such drugs and leveraging them for successful in-licensing opportunities.

Licensing 96

Licensing Licensing Drugs Biosimilars 96

Drug Patent Watch

DECEMBER 9, 2024

This approach has led to the discovery of numerous potential drug candidates. From Lab to Market: The Long Road of Drug Development Once a promising compound is identified, it enters the long and costly process of drug development. Q: How long does a drug patent last?

Drugs 97

Drugs Drug Development Pharmaceuticals Production 97

Perficient: Drug Development

APRIL 16, 2024

IDC Market Glance: Payer, 2Q24 Perficient is excited to be included in the IDC Market Glance: Payer, 2Q24 (doc #US51961724, April 2024) report. According to IDC, this report “provides a glance at the current makeup of the payer IT landscape, illustrates the vendor landscape, and depicts the segments and structure of the market.”

Marketing 107

Marketing Government 107

Perficient: Drug Development

OCTOBER 9, 2024

IDC Market Glance: Digital Business Professional Services, 3Q24 Perficient is thrilled to be included in the Technology Transformation Dominant consultancy category in the latest IDC Market Glance: Digital Business Professional Services report (doc #US51480824, September 2024).

Marketing 105

Marketing 105

PPD

JANUARY 15, 2025

Accelerate customer speed to market With a modern and integrated user experience, AI solutions put the right data and insights into the right hands in real time. As a result, drug developers make better decisions more quickly (removing 50% of study timeline whitespace) to bring new therapies to market faster.

Clinical Trials 95

Clinical Trials Trials Clinical Research Drug Development 95

DS in Pharmatics

APRIL 18, 2025

Discover the five pillars of drug development consulting: regulatory compliance, clinical trials, preclinical research, CMC, and market access.

Drug Development 52

Drug Development Clinical Trials Compliance Drugs 52

Drug Target Review

APRIL 7, 2025

In a recent survey conducted by ICON, Plc, biomarker selection was identified by 35 percent of respondents as a top challenge among drug developers for phase I trials, second only to navigating regulatory compliance (- 38 percent). Silver Spring (MD): Food and Drug Administration (US); 2016-. 113:9861002.

Clinical Development 69

Clinical Development Clinical Trials Clinical Pharmacology Trials 69

Drug Target Review

JULY 18, 2023

Artificial Intelligence (AI) is poised to transform the field of target discovery in drug development, offering immense potential to enhance efficacy, personalised medicine, and accelerate the development of innovative compounds. Cavlan explains that “they are brilliant at developing and bringing new drugs to market.”

Drug Development 98

Drug Development Drugs Clinical Development Pharmaceutical Companies 98

Antidote

JULY 8, 2022

When you head to the pharmacy to pick up medicine, you likely aren’t thinking about all the steps it had to take to get into your hands — but did you know that on average, it takes about ten years for a new medication to make it to market ?

Pharmacy 98

Pharmacy Drug Development Clinical Trials Research 98

The Premier Consulting Blog

APRIL 13, 2025

On April 10, 2025, the US FDA announced that it has a long-term plan to eliminate conventional animal testing in drug development, starting with monoclonal antibodies (mAbs).[ from approved products in other countries) to inform doses and development. Legislation with delayed implementation In 2021, the FDA Modernization Act 2.0

Animal Testing 52

Animal Testing FDA Drug Development Production 52

Perficient: Drug Development

AUGUST 23, 2023

IDC Market Glance: Digital Business Professional Services Perficient is excited to be included in the IDC Market Glance: Digital Business Professional Services, 3Q23, doc #US51069222, August 2023 report.

Marketing 97

Marketing 97

Fierce BioTech

NOVEMBER 22, 2024

AI in Pharma: Benefits, Risks and the Road Ahead AI is revolutionizing the drug development process, streamlining and accelerating every stage, from research to approval and marketing. This whitepaper explores the benefits and risks of AI in the pharmaceutical industry and examines its future.

Drug Development 52

Drug Development Pharmaceuticals Marketing Research 52

Drug Target Review

AUGUST 7, 2024

The pharmaceutical industry is undergoing a major shift towards the development of breakthrough medicines and advanced therapies. This continued innovation highlights the complexity of the drug development process, particularly as the field is highly regulated by health authorities around the world.

Drug Development 59

Drug Development Clinical Pharmacology Clinical Trials Drugs 59

Drug Patent Watch

DECEMBER 10, 2024

Generic drug development is a complex process that requires a deep understanding of regulatory requirements and guidelines. Regulatory expertise plays a crucial role in ensuring that generic drugs meet the necessary standards for quality, safety, and efficacy. EU, and other regions.

Drug Development 52

Drug Development Compliance Drugs Regulations 52

Perficient: Drug Development

JANUARY 16, 2024

Personalization (formerly known as Interaction Studio) is a tool that exists inside the Salesforce Marketing Cloud tenant. In this case, we want to know where the user is for marketing and statistical purposes, and not punish our user in the same way Lotso wants to catch the toys. The sitemap is the heart of personalization.

Marketing 64

Marketing Production 64

Drug Target Review

APRIL 14, 2025

The antibiotic market has long faced significant barriers to innovation, with structural issues that make it difficult for new antibiotics to gain traction. As the demand for novel antibiotics remains limited due to the preference for cheaper generics, the market has struggled to incentivise much-needed breakthroughs.

Therapies 52

Therapies Marketing Drug Development Treatment 52

Perficient: Drug Development

SEPTEMBER 6, 2024

Salesforce’s position as a leader in this report reflects its current offerings, robust strategy, and strong market influence. Strategy: Forrester evaluates the vendor’s long-term vision, innovation roadmap, and ability to address future market needs.

Marketing 59

Marketing Compliance Production Engineering 59

DrugBank

APRIL 3, 2025

Advances in predictive modeling, high-throughput screening, and omics technologies have provided powerful tools to uncover safety risks early in the drug development pipeline. Liver-on-chip models, for instance, have been instrumental in understanding drug-induced liver injury , a leading cause of market withdrawals.

Drug Development 52

Drug Development Drugs Clinical Trials Pharmacokinetics 52